Activist 13D/13G Filings - Prevail Therapeutics Inc. (PRVL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2021-02-16
4:39 pm
Sale
13GPrevail Therapeutics Inc.
PRVL
RA CAPITAL MANAGEMENT L.P.0
0%
-3,363,605decrease
(Position Closed)
View
2021-02-16
4:30 pm
Purchase
13GPrevail Therapeutics Inc.
PRVL
CITADEL ADVISORS LLC2,421,024
7.1%
7,143increase
(+0.30%)
View
2021-02-12
4:19 pm
Sale
13GPrevail Therapeutics Inc.
PRVL
REGENXBIO Inc.
RGNX
0
0%
-2,030,000decrease
(Position Closed)
View
2021-02-12
4:06 pm
Sale
13GPrevail Therapeutics Inc.
PRVL
EcoR1 Capital LLC0
0%
-2,248,306decrease
(Position Closed)
View
2021-01-29
4:15 pm
Unchanged
13GPrevail Therapeutics Inc.
PRVL
JNE Partners LLP0
0%
0
(Unchanged)
View
2021-01-28
8:30 pm
Sale
13DPrevail Therapeutics Inc.
PRVL
ORBIMED ADVISORS LLC0
0%
-13,822,463decrease
(Position Closed)
View
2020-12-22
08:49 am
Purchase
13DPrevail Therapeutics Inc.
PRVL
ELI LILLY & Co
LLY
18,858,511
53.3%
18,858,511increase
(New Position)
View
2020-10-08
4:02 pm
Purchase
13GPrevail Therapeutics Inc.
PRVL
CITADEL ADVISORS LLC2,413,881
7.1%
2,413,881increase
(New Position)
View
2020-02-14
4:34 pm
Purchase
13GPrevail Therapeutics Inc.
PRVL
RA CAPITAL MANAGEMENT L.P.3,363,605
9.9%
3,363,605increase
(New Position)
View
2020-02-14
2:38 pm
Sale
13GPrevail Therapeutics Inc.
PRVL
EcoR1 Capital LLC2,248,306
6.6%
-144,250decrease
(-6.03%)
View
2020-02-13
5:12 pm
Purchase
13GPrevail Therapeutics Inc.
PRVL
Abeliovich Asa2,988,428
8.6%
2,988,428increase
(New Position)
View
2020-02-13
4:29 pm
Purchase
13GPrevail Therapeutics Inc.
PRVL
REGENXBIO Inc.
RGNX
2,030,000
5.95%
2,030,000increase
(New Position)
View
2019-06-28
4:17 pm
Purchase
13GPrevail Therapeutics Inc.
PRVL
EcoR1 Capital LLC2,392,556
7%
2,392,556increase
(New Position)
View
2019-06-27
1:20 pm
Purchase
13DPrevail Therapeutics Inc.
PRVL
ORBIMED ADVISORS LLC13,822,463
40.7%
13,822,463increase
(New Position)
View